Related Experiment Video
Updated: Jul 20, 2026

Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
[Microparticles during sepsis and trauma. A link between inflammation and thrombotic processes]
N Morel1, O Morel, X Delabranche
1Service d'urgences et de réanimation chirurgicale, hôpital Pellegrin, Bordeaux, France.
Abstract:
Sepsis and trauma lead to a sustained activation of monocytes and endothelium. In the vascular compartment, stimulated cells release microparticles. Circulating MP provide an additional procoagulant phospholipid surface enabling the assembly of the clotting enzymes complexes and thrombin generation. Their procoagulant properties rely on the exposition of phosphatidylserine, made accessible after cell stimulation and on the possible presence of tissue factor, the main cellular initiator of blood coagulation. Microparticles constitute the main reservoir of blood-borne tissue factor activity. At sites of endothelium injury, enhanced release or recruitment of procoagulant MP through P-selectin-PSGL-1 pathway could concentrate TF activity above a threshold allowing blood coagulation to be triggered. Converging evidences from experimental or clinical data highlight a role for MP harboring tissue factor in the initiation of disseminated intravascular coagulopathy. In these settings, the pharmacological modulation of MP levels or biological functions through activated protein C or factor VIIa allows challenging issues.
Insights
Sepsis and trauma activate cells, releasing microparticles (MPs) that promote blood clotting and thrombin generation. These MPs, rich in tissue factor, are implicated in initiating disseminated intravascular coagulopathy.
Area of Science:
- Vascular biology
- Hemostasis
- Cellular signaling
Context:
- Sepsis and trauma induce sustained monocyte and endothelial activation.
- Activated cells release microparticles (MPs) into the vascular compartment.
- Circulating MPs offer a procoagulant phospholipid surface for clotting enzyme complex assembly.
Purpose:
- To investigate the role of microparticles in coagulation.
- To understand the procoagulant properties of MPs.
- To explore the contribution of MPs to disseminated intravascular coagulopathy.
Summary:
- MPs expose phosphatidylserine and can carry tissue factor (TF), the primary initiator of coagulation.
- MPs are a major source of blood-borne TF activity.
- TF-bearing MPs at injury sites can concentrate TF activity, triggering blood coagulation.
- Evidence links TF-bearing MPs to the initiation of disseminated intravascular coagulopathy.
Impact:
- Highlights the critical role of MPs in thrombosis and hemostasis.
- Suggests MPs as potential therapeutic targets.
- Pharmacological modulation of MPs may offer new treatment strategies for coagulopathies.
Related Concept Videos
Acute Inflammation III: Local and Systemic Effects
Inflammation
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Bacterial Meningitis II: Pathophysiology
Chronic Inflammation: Introduction
Acute Inflammation I: Inflammatory Response
